NASDAQ:AMEH Apollo Medical (AMEH) Stock Price, News & Analysis → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free AMEH Stock Alerts $40.82 -0.88 (-2.11%) (As of 02/23/2024) Add Compare Share Share Today's Range$40.71▼$42.7550-Day Range$34.75▼$41.7052-Week Range$28.86▼$43.12Volume313,900 shsAverage Volume166,711 shsMarket Capitalization$2.38 billionP/E Ratio40.82Dividend YieldN/APrice Target$47.20 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Apollo Medical alerts: Email Address Apollo Medical MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.80 Rating ScoreUpside/Downside15.6% Upside$47.20 Price TargetShort InterestN/ADividend StrengthN/ASustainability-0.69Upright™ Environmental ScoreNews SentimentN/AInsider TradingN/AProj. Earnings Growth32.50%From $1.20 to $1.59 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.95 out of 5 starsMedical Sector570th out of 939 stocksManagement Consulting Services Industry12th out of 18 stocks 2.4 Analyst's Opinion Consensus RatingApollo Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $47.20, Apollo Medical has a forecasted upside of 15.6% from its current price of $40.82.Amount of Analyst CoverageApollo Medical has only been the subject of 3 research reports in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for AMEH. Previous Next 0.0 Dividend Strength Dividend YieldApollo Medical does not currently pay a dividend.Dividend GrowthApollo Medical does not have a long track record of dividend growth. Previous Next 4.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreApollo Medical has received a 64.92% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Health care management software" and "Management consulting for medical care" products. See details.Environmental SustainabilityThe Environmental Impact score for Apollo Medical is -0.69. Previous Next 0.0 News and Social Media Coverage MarketBeat FollowsOnly 2 people have added Apollo Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Apollo Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 8.46% of the stock of Apollo Medical is held by insiders.Percentage Held by InstitutionsOnly 35.88% of the stock of Apollo Medical is held by institutions. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Apollo Medical are expected to grow by 32.50% in the coming year, from $1.20 to $1.59 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Apollo Medical is 40.82, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 136.36.Price to Earnings Ratio vs. SectorThe P/E ratio of Apollo Medical is 40.82, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 185.37.Price to Earnings Growth RatioApollo Medical has a PEG Ratio of 1.15. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioApollo Medical has a P/B Ratio of 4.25. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad DTIWarning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…Watch the presentation here About Apollo Medical Stock (NASDAQ:AMEH)Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services in the United States. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was incorporated in 1985 and is headquartered in Alhambra, California.Read More AMEH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AMEH Stock News HeadlinesMarch 19, 2024 | yahoo.comApollo Returns & More Must-See Moments from Married to Med's Season 10 Reunion FinaleFebruary 29, 2024 | finance.yahoo.comAstrana Health Full Year 2023 Earnings: EPS Beats ExpectationsMarch 28, 2024 | DTI (Ad)the most reliable asset on earth is making a comebackGlobal tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.February 27, 2024 | finance.yahoo.comAstrana Health Inc (ASTH) Reports Growth in Revenue and Net Income for Q4 and Full Year 2023February 27, 2024 | msn.comJefferies Initiates Coverage of Apollo Medical Holdings (AMEH) with Buy RecommendationFebruary 26, 2024 | investorplace.comThe 3 Most Popular Stocks Owned by Congress in Q1February 26, 2024 | markets.businessinsider.comApollo Medical earnings preview: what Wall Street is expectingFebruary 23, 2024 | msn.comB of A Securities Upgrades Apollo Medical Holdings (AMEH)March 28, 2024 | DTI (Ad)Warning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…February 22, 2024 | msn.comApollo Medical to change name to Astrana HealthFebruary 22, 2024 | msn.comApollo Medical upgraded to buy at BoA on revenue, earnings growthFebruary 22, 2024 | finance.yahoo.comApollo Medical Holdings, Inc. Becomes Astrana Health, Inc.February 22, 2024 | prnewswire.comApollo Medical Holdings, Inc. Becomes Astrana Health, Inc.February 20, 2024 | finance.yahoo.comApollo Medical Holdings, Inc. (AMEH) Reports Next Week: Wall Street Expects Earnings GrowthFebruary 15, 2024 | finance.yahoo.comAMEH May 2024 30.000 callFebruary 15, 2024 | finance.yahoo.comAMEH May 2024 25.000 putFebruary 15, 2024 | wsj.comApollo Medical Holdings Inc.February 14, 2024 | msn.comApollo Health moves to Oracle Fusion Cloud ERP for managing financial operationsFebruary 8, 2024 | msn.comApollo PAT up 60% on robust growth across businessesFebruary 8, 2024 | investing.comApollo Medical Holdings Inc (AMEH)February 8, 2024 | msn.comApollo Hospitals Q3 Results: Net profit rises 60% to Rs 245 croreFebruary 8, 2024 | finance.yahoo.comAn excellent week for Apollo Medical Holdings, Inc.'s (NASDAQ:AMEH) institutional owners who own 47% as one-year returns inch higherJanuary 31, 2024 | finance.yahoo.comApollo Medical Holdings, Inc. Schedules 2023 Fourth Quarter and Full Year Financial Results Release and Conference CallJanuary 30, 2024 | msn.comApolloMed and BASS partner to enhance value-based healthcareJanuary 29, 2024 | finanznachrichten.deApollo Medical Holdings, Inc.: ApolloMed and BASS Medical Group to Forge a Value-Based Healthcare PartnershipJanuary 24, 2024 | markets.businessinsider.comApollo Medical Holdings Names Brandon Sim CEO, Chan Basho COOJanuary 24, 2024 | finance.yahoo.comApollo Medical Holdings, Inc. Announces Planned Corporate Rebrand as Astrana HealthSee More Headlines Receive AMEH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Apollo Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/04/2021Today3/28/2024Next Earnings (Estimated)5/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Management consulting services Sub-IndustryN/A Current SymbolNASDAQ:AMEH CUSIPN/A CIK1083446 Webwww.apollomed.net Phone(626) 282-0288Fax818-839-5190Employees1,362Year FoundedN/APrice Target and Rating Average Stock Price Target$47.20 High Stock Price Target$55.00 Low Stock Price Target$41.00 Potential Upside/Downside+15.6%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$1.00 Trailing P/E Ratio40.82 Forward P/E Ratio34.02 P/E Growth1.15Net Income$45.17 million Net Margins3.56% Pretax Margin7.48% Return on Equity9.90% Return on Assets5.51% Debt Debt-to-Equity Ratio0.35 Current Ratio2.35 Quick Ratio2.35 Sales & Book Value Annual Sales$1.14 billion Price / Sales2.08 Cash Flow$1.26 per share Price / Cash Flow32.51 Book Value$9.60 per share Price / Book4.25Miscellaneous Outstanding Shares58,280,000Free Float53,353,000Market Cap$2.38 billion OptionableOptionable Beta1.04 Social Links Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesDr. Kenneth T. Sim M.D. (Age 70)Executive Chairman Comp: $1.49MMr. Brandon Sim (Age 29)President & CEO Comp: $1.73MMr. Chandan Basho (Age 41)CFO & COO Comp: $581.42kDr. WaiChow Young M.D. (Age 77)Chief Administrative Officer Comp: $573.67kMr. John Vong (Age 51)Chief Accounting Officer Dr. Jeremy R. Jackson M.D.Chief Quality OfficerMr. Neil AhujaPresident of Provider SolutionsYubin ParkChief Data & Analytics OfficerDr. Carlos Palacios M.D.Chief Medical Officer for TexasDr. Dinesh M. Kumar M.D. (Age 55)Chief Medical Officer More ExecutivesKey CompetitorsAstrana HealthNASDAQ:ASTHRhythm PharmaceuticalsNASDAQ:RYTMKeros TherapeuticsNASDAQ:KROSTG TherapeuticsNASDAQ:TGTXCONMEDNYSE:CNMDView All CompetitorsInstitutional OwnershipVanguard Group Inc.Bought 260,687 shares on 3/11/2024Ownership: 8.665%Price T Rowe Associates Inc. MDBought 1,086 shares on 2/16/2024Ownership: 0.051%Price T Rowe Associates Inc. MDBought 1,086 shares on 2/15/2024Ownership: 0.051%Comerica BankBought 611 shares on 2/15/2024Ownership: 0.035%Citadel Advisors LLCSold 200 shares on 2/15/2024Ownership: 0.000%View All Institutional Transactions AMEH Stock Analysis - Frequently Asked Questions Should I buy or sell Apollo Medical stock right now? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apollo Medical in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AMEH shares. View AMEH analyst ratings or view top-rated stocks. What is Apollo Medical's stock price target for 2024? 5 Wall Street analysts have issued 1 year target prices for Apollo Medical's shares. Their AMEH share price targets range from $41.00 to $55.00. On average, they expect the company's stock price to reach $47.20 in the next year. This suggests a possible upside of 15.6% from the stock's current price. View analysts price targets for AMEH or view top-rated stocks among Wall Street analysts. How have AMEH shares performed in 2024? Apollo Medical's stock was trading at $38.30 at the beginning of the year. Since then, AMEH shares have increased by 6.6% and is now trading at $40.82. View the best growth stocks for 2024 here. When is Apollo Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024. View our AMEH earnings forecast. How were Apollo Medical's earnings last quarter? Apollo Medical Holdings, Inc. (NASDAQ:AMEH) released its quarterly earnings results on Thursday, November, 4th. The company reported $0.69 EPS for the quarter, topping analysts' consensus estimates of $0.34 by $0.35. The firm had revenue of $227.12 million for the quarter. Apollo Medical had a trailing twelve-month return on equity of 9.90% and a net margin of 3.56%. During the same period in the previous year, the company posted $0.45 EPS. What ETFs hold Apollo Medical's stock? ETFs with the largest weight of Apollo Medical (NASDAQ:AMEH) stock in their portfolio include Fidelity Digital Health ETF (FDHT), Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS) and Syntax Stratified SmallCap ETF (SSLY).iShares U.S. Healthcare Providers ETF (IHF). What guidance has Apollo Medical issued on next quarter's earnings? Apollo Medical issued an update on its FY 2023 earnings guidance on Tuesday, January, 30th. The company provided EPS guidance of 1.100-1.200 for the period, compared to the consensus earnings per share estimate of 1.200. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion. What is Thomas Lam's approval rating as Apollo Medical's CEO? 15 employees have rated Apollo Medical Chief Executive Officer Thomas Lam on Glassdoor.com. Thomas Lam has an approval rating of 43% among the company's employees. This puts Thomas Lam in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. 28.0% of employees surveyed would recommend working at Apollo Medical to a friend. What other stocks do shareholders of Apollo Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include PayPal (PYPL), SEA (SE), Mastercard (MA), NVIDIA (NVDA), Walt Disney (DIS), Lululemon Athletica (LULU), Enphase Energy (ENPH), Main Street Capital (MAIN), Block (SQ) and Exxon Mobil (XOM). Who are Apollo Medical's major shareholders? Apollo Medical's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (8.66%), Vanguard Group Inc. (8.66%), Dimensional Fund Advisors LP (1.32%), SteelPeak Wealth LLC (1.16%), Northern Trust Corp (0.78%) and Charles Schwab Investment Management Inc. (0.59%). Insiders that own company stock include Albert Waichow Young, Brandon Sim, Linda Marsh and Physicians Of Californi Allied. View institutional ownership trends. How do I buy shares of Apollo Medical? Shares of AMEH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Does Apollo Medical have any subsidiaries? The following companies are subsidiares of Apollo Medical: Standard Aero (alliance) Inc..Read More This page (NASDAQ:AMEH) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apollo Medical Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.